Infectious Disease

COVID-19 tests free once again; spacecraft researching HIV drug denied reentry

September 26, 2023

1 min read

ADD TOPIC TO EMAIL ALERTS

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .


data-action=”subscribe”>
Subscribe

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

Back to Healio

The U.S. government is offering its fifth round of free at-home tests for COVID-19, with four tests per household available at COVIDTests.gov as of Monday, Sept. 25.

The tests, which can detect SARS-CoV-2 variants currently circulating, come as the most recent CDC data reflected a 7.7% increase in COVID-19-related hospitalizations in the U.S. from Sept. 3 to 9.

Free at-home COVID-19 tests became available once again to Americans this week. Each household can order up to four tests through COVIDTests.gov. Image: Adobe Stock

It was the top story in infectious disease last week.

In another top story, U.S. agencies denied a request for reentry from the first-ever private spacecraft used for pharmaceutical research.

Read these and more top stories in infectious disease below:

US relaunches program providing free at-home COVID-19 tests

Free at-home COVID-19 tests are available for mail order again in the United States. Read more.

Spacecraft experimenting with HIV drug denied reentry to US

A spacecraft being used to manufacture a crystalized version of the HIV drug ritonavir in low Earth orbit has been denied reentry and permission to land in the United States, Healio confirmed. Read more.

Face shields are protective but should be paired with other PPE

When worn by health care personnel, a face shield was effective at reducing exposure to aerosol particles containing virus from a simulated coughing machine, researchers reported. Read more.

Fewer adults hospitalized with COVID-19 had critical outcomes as pandemic progressed

Adults hospitalized with COVID-19 were less likely to experience critical outcomes such as ICU admission, respiratory failure or death during later periods of the pandemic, researchers found. Read more.

Rifampin improves treatment for S. aureus native vertebral osteomyelitis

Rifampin-based regimens for treating Staphylococcus aureus native vertebral osteomyelitis were associated with lower risk of clinical failure, according to a study published in Clinical Infectious Diseases. Read more.

ADD TOPIC TO EMAIL ALERTS

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .


data-action=”subscribe”>
Subscribe

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

Back to Healio

Related Articles